fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Successful penicillin allergy de-labelling

Written by | 24 Mar 2025

29th EAHP Congress highlights Approximately 10% of inpatients are labelled as ‘allergic to penicillin’ but the vast majority have not experienced a true allergic reaction. Having a penicillin… read more.

Penicillin allergy delabeling in syphilis patients assists in furthering treatment

Written by | 28 Oct 2024

About 10% of Americans believe they are allergic to penicillin, and approximately 90% of those patients are not actually allergic. As a result, those with the penicillin allergy… read more.

Peering into the mind of artificial intelligence to make better antibiotics

Written by | 20 Aug 2024

Artificial intelligence (AI) has exploded in popularity. It powers models that help us drive vehicles, proofread emails and even design new molecules for medications. But just like a… read more.

Removal of incorrect penicillin allergy labels by non-specialist healthcare professional feasible

Written by | 23 Mar 2024

Patients who may have been mis-labelled as allergic to penicillin could be safely offered a dose of the oral antibiotic to demonstrate that they could take it without… read more.

Evidence-based approaches to penicillin allergy de-labelling

Written by | 17 Nov 2023

Neil Powell combines the roles of consultant antimicrobial pharmacist and clinical researcher at the Royal Cornwall Hospital in Truro. In this series of short videos, he describes the… read more.

What does a consultant antimicrobial pharmacist do?

Written by | 16 Nov 2023

The work of a consultant antimicrobial pharmacist involves not only knowing about antimicrobial medicines but also understanding how people and organisations behave and collaborating with others to optimise… read more.

Could penicillin allergy de-labelling lead to better outcomes?

Written by | 15 Nov 2023

Implementation of penicillin allergy de-labelling calls for an understanding of the key barriers and enablers in healthcare systems – topics that the iNAAN and ALABAMA studies address, explains… read more.

What the PALACE study tells us about penicillin allergy de-labelling

Written by | 14 Nov 2023

The PALACE study showed that in people at low-risk of penicillin allergy, a direct oral challenge with penicillin was no less effective than standard allergy testing for determining… read more.

Why penicillin allergy labels might be a bad thing

Written by | 13 Nov 2023

Neil Powell combines the roles of a consultant antimicrobial pharmacist and a clinical researcher at the Royal Cornwall Hospital in Truro.  His current research is focused on the… read more.

Removing incorrect penicillin allergy labels in a UK hospital

Written by | 25 Aug 2023

Incorrect penicillin allergy labels can result in patients receiving less effective or more toxic antimicrobial agents but a pilot study has shown that a pharmacy-led multidisciplinary team can… read more.

Outcomes of penicillin allergy de-labelling

Written by | 24 Aug 2023

A total of 56 patients were successfully de-labelled in the pilot study but a key challenge will be preventing the erroneous reappearance of the penicillin allergy label, according… read more.

Why should we de-label ‘penicillin-allergic’ patients?

Written by | 23 Aug 2023

Incorrect penicillin allergy labels can result in patients receiving less effective or more toxic antimicrobial agents but a recent publication has shown that a pharmacy-led multidisciplinary team can… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.